Right Anterolateral Thoracotomy: an Attractive Alternative to Repeat Sternotomy for High-Risk Patients Undergoing Reoperative Mitral and Tricuspid Valve Surgery.

Hailong Cao,Qing Zhou,Fudong Fan,Yunxing Xue,Jun Pan,Dongjin Wang
DOI: https://doi.org/10.1186/s13019-017-0645-x
2017-01-01
Journal of Cardiothoracic Surgery
Abstract:BACKGROUND:Reoperative cardiac valve surgery via sternotomy is associated with a substantial morbidity and mortality. This study evaluated the right anterolateral thoracotomy for high-risk patients undergoing mitral and tricuspid valve redo procedures.METHODS:Out of a series of 173 patients undergoing redo cardiac valve surgery, 24 patients were reoperative via the right anterolateral thoracotomy as the high-risk group on the basis of the proximity of the heart and great vessels to the sternum and the presence and location of patent bypass grafts.RESULTS:In all cases, sternotomy was avoided. The mitral valve and tricuspid valve were replaced in 4 and 19 patients and repaired in 1 and 2 patients, respectively. Moreover, left atrial folding was performed in 5 patients. Mortality was 8.3%. All other patients had uneventful outcomes and normal valve function at follow-up.CONCLUSIONS:Reoperative cardiac valve surgery can be performed safely using the right anterolateral thoracotomy in high-risk patients. It offers enough exposure. It minimizes the need for cardiac dissection, and thus, the risk for injury. Avoiding a high-risk resternotomy increases patients comfort and safety of redo mitral and tricuspid valve surgery.
What problem does this paper attempt to address?